India Cements shares surge 5% on strong demand, despite weak market sentiments.
ByAinvest
Monday, Jun 23, 2025 12:54 am ET1min read
CRML--
The buying pressure on India Cements shares came after the company's board approved the sale of ICML to Mirai Sensing Private Limited. Upon completion, ICML will cease to be a subsidiary of India Cements. The sale is expected to be finalized within six months from the date of the agreement [2].
The stock's performance is notable as it comes amidst a broader weak market sentiment, with the BSE Sensex down 1.02% at 81,563.81. The company's market capitalization stood at ₹9,630.06 crore, with a 52-week high of ₹385.5 per share and a 52-week low of ₹223.7 per share [1].
India Cements, a subsidiary of UltraTech Cement Limited, is the largest manufacturer of grey cement and ready mix concrete (RMC) in India. The company, founded in 1946, has grown to a total current cement production capacity of 14.45 million tonnes per annum, with eight integrated cement plants and one grinding unit across various states [3].
References:
[1] https://www.business-standard.com/markets/news/india-cements-share-price-gains-5-percent-in-weak-market-nse-block-deal-franklin-templeton-mutual-fund-125062300218_1.html
[2] https://www.etnownews.com/markets/india-cements-stake-sale-aditya-birla-group-firm-to-sell-this-subsidiary-big-approval-in-board-meeting-today-article-152123929
[3] https://economictimes.indiatimes.com/industry/indl-goods/svs/cement/india-cements-to-sale-its-subsidiary-industrial-chemicals/articleshow/121994040.cms
ICL--
XYZ--
India Cements shares surged 5% to a high of ₹318.5 per share on BSE, despite a weak market. The rally came after the company announced plans to sell its equity investment in Industrial Chemicals and Monomers Limited, a subsidiary, for ₹97.68 crore. Franklin Templeton Mutual Fund also bought 2.04 million shares at ₹310.17 per share.
India Cements Limited (ICL) shares surged 5% to a high of ₹318.5 per share on the BSE, despite a weak market, on Monday, June 23, 2025. The rally was driven by the company's announcement to sell its equity investment in Industrial Chemicals and Monomers Limited (ICML), a subsidiary, for ₹97.68 crore. Additionally, Franklin Templeton Mutual Fund purchased 2.04 million shares at ₹310.17 per share, according to National Stock Exchange (NSE) block deal data [1].The buying pressure on India Cements shares came after the company's board approved the sale of ICML to Mirai Sensing Private Limited. Upon completion, ICML will cease to be a subsidiary of India Cements. The sale is expected to be finalized within six months from the date of the agreement [2].
The stock's performance is notable as it comes amidst a broader weak market sentiment, with the BSE Sensex down 1.02% at 81,563.81. The company's market capitalization stood at ₹9,630.06 crore, with a 52-week high of ₹385.5 per share and a 52-week low of ₹223.7 per share [1].
India Cements, a subsidiary of UltraTech Cement Limited, is the largest manufacturer of grey cement and ready mix concrete (RMC) in India. The company, founded in 1946, has grown to a total current cement production capacity of 14.45 million tonnes per annum, with eight integrated cement plants and one grinding unit across various states [3].
References:
[1] https://www.business-standard.com/markets/news/india-cements-share-price-gains-5-percent-in-weak-market-nse-block-deal-franklin-templeton-mutual-fund-125062300218_1.html
[2] https://www.etnownews.com/markets/india-cements-stake-sale-aditya-birla-group-firm-to-sell-this-subsidiary-big-approval-in-board-meeting-today-article-152123929
[3] https://economictimes.indiatimes.com/industry/indl-goods/svs/cement/india-cements-to-sale-its-subsidiary-industrial-chemicals/articleshow/121994040.cms

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet